Announcements Trials
Browse Landscape

Phase

Phase 3 3Phase 2 1Phase 1 1

Status

Recruiting 12Completed 5Unknown 2Not yet recruiting 2Terminated 1Active not recruiting 1

Sponsor Class

OTHER 5

Study Type

Interventional 5

Sponsor

Cancer Type

Other 1Gastrointestinal 1

Conditions

Polycystic Ovary Syndrome 3Pancreatic Neoplasms 1Obesity 1Cardiotoxicity 1

Interventions

Cyclophosphamide 1492Cisplatin 1414Paclitaxel 1317Radiotherapy 1261Carboplatin 1250Gemcitabine 1215Docetaxel 1109Bevacizumab 1030Fluorouracil 894Doxorubicin 792Dexamethasone 748Rituximab 719Capecitabine 716Oxaliplatin 700pembrolizumab 680Etoposide 678Irinotecan 634Filgrastim 621Cytarabine 586Leucovorin 579Nivolumab 558Vincristine 515Prednisone 475Cetuximab 465Bortezomib 459Erlotinib Hydrochloride 456Trastuzumab 447Methotrexate 438Lenalidomide 427Pemetrexed 420

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

5 trials
RecentStart dateEnrollment
Completed × Interventional × dapagliflozin × Clear all
NCT06405178 2026-06-02

Adjuvant Therapy With Letrozole in Induction of Ovulation With Polycystic Ovarian Syndrome

Beni-Suef University

Phase 3 Completed
200 enrolled

Polycystic Ovary Syndrome

NCT06888505 2025-09-18

DAPA-AIC

Hawler Medical University

Phase 2 Completed
90 enrolled

Cardiotoxicity

NCT04542291 2023-02-14

Targeting Pancreatic Cancer With Sodium Glucose Transporter 2 (SGLT2) Inhibition

Washington University School of Medicine

Phase 1 Completed
15 enrolled 15 charts
Gastrointestinal

Pancreatic Neoplasms

NCT04213677 2023-01-12

DEAP

Nanfang Hospital, Southern Medical University

Phase 3 Completed
165 enrolled

Polycystic Ovary Syndrome

NCT02635386 2021-01-29

EQW, DAPA, EQW/DAPA, DAPA/MET ER and PHEN/TPM ER in Obese Women With PolycysticOvary Syndrome (PCOS)

Woman's

Phase 3 Completed
119 enrolled 34 charts
Other

Obesity, Polycystic Ovary Syndrome

Data powered by HemOnc (CC BY 4.0) Colophon âš¡